Ciprofloxacin administration to very low birth weight babies has no effect on linear growth in infancy

Journal of Tropical Pediatrics

Volumn 52, Issue 2, 2006, Pages 103-106

  Dutta, Sourabh ^a   Chowdhary, Gurdev ^a   Kumar, Praveen ^a   Mukhopadhay, Kanya ^a   Narang, Anil ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ARTICLE; BODY HEIGHT; CHILD GROWTH; COHORT ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG USE; FEMALE; FOLLOW UP; GESTATIONAL AGE; GROWTH RETARDATION; HUMAN; INFANCY; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NEWBORN INFECTION; NEWBORN PERIOD; PREMATURITY; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT DURATION; VERY LOW BIRTH WEIGHT;

ANTI-INFECTIVE AGENTS; CASE-CONTROL STUDIES; CIPROFLOXACIN; FEMALE; GROWTH; HUMANS; INDIA; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; LINEAR MODELS; MALE; RETROSPECTIVE STUDIES;

EID: 33645845722     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmi070     Document Type: Article

References (26)

1. Burkhart J, Walterspiel J, Schaad UB. Quinolone arthropathy in animals versus children. Clin Infect Dis 1997; 25: 1196-204.
2. Linseman Da, Hampton LA, Branstetter DG. Quinolone induced arthropathy in the neonatal mouse: Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin. Fundam Appl Toxicol 1995; 28: 59-64.
3. Stahhnann R, Merker HJ, Ffinz N, et al. Ofloxacin in juvenile non-human primates and rats: Arthropathy and drug plasma concentrations. Arch Toxicol 1990; 64: 193-204.
4. Schaad UB, Salam MA, Aujard Y. Use of fluoroquinolones in pediatrics: Consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J 1995; 14(Suppl 1): 1-9.
5. Schaad UB. Use of the new quinolones in pediatrics. Isr J Med Sci 1994; 30(5-6): 463-68.
6. Hampel B, Hullman R, Scmidt H. Ciprofloxacin use in pediatrics: worldwide clinical experience based on compassionate use-safety report. Pediatr Infect Dis J 1997; 16: 127-29.
7. Singh UK, Sinha RK, Prasad B, Chakrabarti B, Sharma SK. Ciprofloxacin in children: Is arthropathy a limitation? Indian J Pediatr 2000; 67(5): 386-87.
8. Orenstein DM, Pattishall EN, Noyes BE, Kurland G, Hartigan ER, Yu VL. Safety of ciprofloxacin in children with cystic fibrosis. Clin Pediatr (Phila) 1993; 32: 504-06.
9. Chysky V, Kapila K, Hullman R, Arciery G, Schacht P, Echols R. Safety of ciprofloxacin in children: Worldwide clinical experience based on compassionate use - emphasis on joint evaluation. Infection 1991; 19: 289-96.
10. Richard DA, Nousia-Arvanitakis S, Sollich V, Hampel BJ, Sommeraur B, Schaad UB. Oral eirofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: Comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance. Pediatr Infect Dis J 1997; 16: 572-78.
11. Church DA, Kanga JF, Kuhn RJ, et al. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: Comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. Pediatr Infect Dis J 1997; 16: 97-105.
12. Wlazlowski J, Krzyzanska-Oberbek A, Sikora JP, Chlebna-Sokol D. Use of quinolones in treatment of severe bacterial infections in premature infants. Acta Pol Pharm 2000; 57 (Suppl): 28-31.
13. Van den Oever HLA, Versteegh FGA, Thewessen EAPM, et al. Ciprofloxacin in preterm neonates: Case report and review of literature. Eur J Pediatr 1998; 157: 843-45.
14. Chotigeat AN, Balkan E, Kilic N, Kiristioglu I, et al. Successful treatment of late onset infection due to multidrug resistant Acinetobacter lwoffi in a low birth weight neonate using ciprofloxacin. J Med Assoc Thai 2001; 84: 910-13.
15. Mishra A, Mishra S, Jaganath G, Mittal RK, Gupta PK, et al. Acenetobacter sepsis in newborns. Indian Pediatr 1998; 35: 27-32.
16. Belobovodova NV, Birggarkov AV, Kurchakov VA. Clinical and bacteriological experience with ciprofloxacin in neonates [Abstract N 129]. In: Rubenstein E (ed), Fifth Symposium on New Quinolones, Singapore, August 28 to 30, 1994.
17. Kremery Jr V, Filka J, Uher, et al. Ciprofloxacin on treatment of neonatal meningitis in neonates and in infants: Report of 12 cases and review. Diagn Microbiol Infect Dis 1999; 35: 75-80.
18. Issacs D, Slach MPE, Wilkinsu AR, et al. Successful treatment of Pseudomonas ventriculitis with ciprofloxacin. J Antimicrob Chemother 1986; 7: 535-38.
19. Drossou-Agakidou V, Roilides E, Papakyriakidou-Koliouska P, Agakidis C, Nikolaides N, Sarafidis K, Kremenopoulos G. Use of ciprofloxacin in neonatal sepsis: Lack of adverse effects up to one year. Pediatr Infect Dis J 2004 Apr; 23(4): 346-49.
20. Gurpinar AN, Balkan E, Kilic N, et al. The effects of a fluoroquinolone on the growth and development of infants. J Int Med Res 1997; 25: 302-06.
21. Chaudhari S, Suryawanshi P, Ambardekar S, Chinchwadkar M, Kinare A. Indian Pediatrics 2004; 41: 1246-51.
22. Kumhar GD, Ramachandran VG, Gupta P. Bacteriological analysis of blood culture isolates from neonates in a tertiary care hospital in India. J Health Popul Nutr 2002; 20: 343-47.
23. Joshi SG, Ghole VS, Niphadkar KB. Neonatal Gram-negative bacteremia. Indian J Pediatr 2000; 67: 27-32.
24. Rodriguez CH, Juarez J, de Mier C, et al. Bacterial resistance to antibiotics in gram-negative rods isolated from intensive care units: comparative analysis between two periods (1998 and 2001). Medicina (B. Aires) 2003; 63: 21-27.
25. Rahman S, Hameed A, Roghani MT, Ullah Z. Multidrug resistant neonatal sepsis in Peshawar, Pakistan. Arch Dis Child Fetal Neonatal Ed 2002; 87: F233.
26. Karki BM, Parija SC. Analysis of blood culture isolates from hospitalized neonates in Nepal. Southeast Asian J Trop Med Public Health 1999; 30: 546-48.